Figure 2From: ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy Overall survival. Without adjuvant chemotherapy (a), with adjuvant chemotherapy (b) (interaction P = 0.034).Back to article page